Optimized hiPSC Platelet Differentiation: Study Insights
2026-08-28
Yue et al. developed an optimized differentiation scheme that combines higher embryoid body input, human platelet lysate, small-molecule replacement of selected cytokines, and enhanced megakaryocyte maturation. The approach produced functional platelets from human induced pluripotent stem cells in a shorter, less expensive workflow, while highlighting important questions about scale-up, reproducibility, and translational validation.
BMS-345541 Hydrochloride: A Translational IKK Strategy
2026-08-28
A mechanistic and translational framework for using BMS-345541 hydrochloride to connect IKK/NF-κB signaling with inflammation research, airway stent biology, and T-cell acute lymphoblastic leukemia models.
Azilsartan Medoxomil: Evidence from a 2024 Meta-Analysis
2026-08-27
A 2024 systematic review and meta-analysis synthesized 11 randomized controlled trials involving 7,608 patients to assess both the antihypertensive efficacy and safety of azilsartan medoxomil. The study found greater reductions in ambulatory and clinic blood pressure at 40 and 80 mg compared with control therapy, without a broad increase in adverse events, while also highlighting the limits of applying pooled clinical findings to smaller diabetes subgroups or laboratory models.
AY 9944 dihydrochloride: Practical DHCR7 Workflows
2026-08-27
Use AY 9944 dihydrochloride to create controlled 7-dehydrocholesterol accumulation, test sterol-dependent membrane organization, and probe immune phenotypes. This workflow separates established product data and genetic evidence from assay conditions that require laboratory optimization.
Hoechst 33258 Maps Tumor Heterogeneity in KRas Studies
2026-08-26
Hoechst 33258 is more than a nuclear counterstain in KRas research: used with careful controls, it can provide spatial, DNA-content, and cell-state context for studies of tunneling nanotube-mediated oncogenic transfer and tumor mechanics. This translational guide connects its bis-benzimide chemistry with experimental design, assay positioning, and preclinical decision-making.
Toremifene versus Tamoxifen in Advanced Breast Cancer
2026-08-26
This Cochrane review evaluated direct clinical evidence comparing the selective estrogen receptor modulators toremifene and tamoxifen in advanced breast cancer. Its central contribution was a structured synthesis showing no convincing efficacy advantage for either treatment, while also clarifying how response, survival, progression, and adverse-event outcomes should guide interpretation of older endocrine-therapy trials.
Site-Specific PEGylation Blocks IL-11 GP130 Signaling
2026-08-25
This study engineered receptor-biased interleukin-11 by selectively PEGylating the GP130-binding interface while preserving IL-11Rα recognition. The optimized conjugates prolonged exposure and reduced bleomycin-induced pulmonary fibrosis in mice, supporting site-specific cytokine engineering as a strategy for separating therapeutic antagonism from unwanted signaling.
TaqI Restriction Endonuclease: Practical Digestion Guide
2026-08-25
TaqI provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA containing its recognition site, with sticky ends that can support cloning workflows. This guide covers setup, gel-based checks, and troubleshooting; the enzyme is for scientific research use only and should not be used for diagnostic or medical applications.
Tropisetron Hydrochloride Assay Workflow
2026-08-24
Build a receptor-to-transporter workflow around Tropisetron Hydrochloride for 5-HT3 signaling, α7-nicotinic receptor studies, and renal drug-interaction assays. The guide separates receptor potency from OCT2/MATE1 transport effects and provides practical setup, controls, troubleshooting, and optimization strategies.
Sodium Dicloxacillin Monohydrate: MIC to PK/PD
2026-08-23
Sodium dicloxacillin monohydrate is examined through an exposure–response framework linking PBPs, intracellular MSSA activity, MIC, pH, and free-drug time above MIC. This evidence-led guide translates the key dicloxacillin PK/PD findings into more interpretable research assays.
Olsalazine Sodium in Cancer and Inflammation Research
2026-08-22
Olsalazine Sodium is a mesalamine dimer and anti-inflammatory prodrug used in experimental inflammation and colorectal cancer research. Product-dossier benchmarks include potent inhibition of LTB4-induced macrophage chemotaxis and reduced tumor burden in a rodent model, while a 2025 mosquito study provides a separate xenobiotic-transport context.
Resiniferatoxin: Engineering TRPV1 Analgesia
2026-08-21
Resiniferatoxin (RTX) turns TRPV1 activation into a translational strategy for durable sensory-neuron silencing. This thought-leadership analysis connects mechanism, route selection, experimental validation, competitive positioning, and clinical development across osteoarthritis, neuropathic pain, cancer pain, and bladder dysfunction.
SLC25A1, Senescence, and HNSCC Cisplatin Resistance
2026-08-20
Li et al. identify SLC25A1 as a metabolic and epigenetic regulator of cisplatin resistance in head and neck squamous cell carcinoma, linking citrate transport and cytosolic acetyl-CoA to H3K27ac-dependent senescence. The study positions SLC25A1 as a candidate biomarker and therapeutic target while clarifying how senescence-associated readouts should be interpreted in chemoresistant tumor models.
(+)-Bicuculline: Workflow and QC Guide
2026-08-20
(+)-Bicuculline is a practical GABAA receptor antagonist for examining inhibitory neurotransmission, GABAergic signaling pathway responses, and related neuronal signaling changes. This dossier-based guide covers preparation, storage, controls, and interpretation; the compound is for controlled neuroscience research only and should not be used for diagnostic, therapeutic, or clinical applications.
Artesunate Workflows for Cancer Drug Response
2026-08-19
Artesunate is an artemisinin derivative suited to cancer assays that separate growth suppression from true cell killing. This guide combines concentration–time screening, ferroptosis and AKT/mTOR-oriented readouts, and practical handling controls for small cell lung carcinoma research and esophageal squamous cell carcinoma models.
459 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page